Campuses

As France's leading biocluster, Genopole is an incubator for cutting-edge projects in biotechnology. Located in the city of Évry, just south of Paris, Genopole provides a unique environment for scientists and entrepreneurs seeking to advance research and innovation.

Discover >

Advantages

Genopole accompanies researchers, postdocs and start-up entrepreneurs through all the phases of their projects to ensure the best possible conditions for business development.

Discover >

Genopole’s citizens

Every day, at Genopole, researchers, entrepreneurs and students cross paths, share ideas and unite forces in a veritable melting pot for innovation.

Discover >

Highlights

Giving wings to research and empowering employment in our community are cornerstones of Genopole's mission. Catch up on recent scientific advances, the accomplishments of our biotech actors and the events that enliven the biocluster.

Discover >

Innovate with us

Discover >
Company

Endodiag


Pépinière Genopole Entreprises
4, rue Pierre Fontaine – Genopole Campus 3
91058 EVRY Cedex – FRANCE

Phone: +33 (0)9 62 50 72 93
Email: contact@endodiag.com

Cécile REAL: CEO
Site Web >
Endodiag - Genopole's company Endodiag - Genopole's company

#Health / Well-being #Diagnostics

  • Endometriosis biomarkers
  • Diagnostic
  • Prognostic
  • Medical devices
  • Personalized medicine

Field of Activity


Design, development and commercialization of medical devices and services for the diagnosis of endometriosis.

BACKGROUND
Endodiag is an innovative biotechnology company fully dedicated to the development of new solutions to improve the diagnosis of endometriosis.

Its management and founding team combines a strong industrial and entrepreneurship experience, over 20 years of pioneering research in the field of endometriosis, and an expertise in the IVD market.
DESCRIPTION OF THE PRODUCTS / SERVICES / TECHNOLOGY
Our first product, EndoGram®, is designed to improve and complement current endometriosis diagnostic practice based on laparoscopic surgery. It combines an innovative biopsy punch to simplify and standardize biopsy collection, a CE-marked sample collection kit and a proprietary method to analyse biological specimens.
EndoGram® provides gynaecologists with important information regarding each patient’s treatment susceptibility and disease aggressiveness.

Our second product EndoTech® & EndoSearch are still under development.
It’s a non-invasive IVD test that will help diagnose endometriosis from a simple blood sample. Based on endometriosis-specific circulating biomarkers it will completely revolutionize the diagnosis of this complex disease by making it easier, cheaper and much faster.

Finally, EndoTesting® is a unique pharmacotesting solution combining multiple assays (cell viability, proliferation, apoptosis, migration, cytotoxicity, invasion, etc.) and a large collection of cell lines and human biological samples.
It is designed to provide early expert information on the potential efficacy of drug candidates against endometriosis.

  • Further information

    4 patents
    15 staff members
    Strengths:
    20 years of research, a complementary management team and a target market with unmet needs.
    Innovation assets:
    Endometriosis biomarkers.
    A unique sampling device, proprietary cell lines.

Share
Genopole’s Companies

#Diagnostics


In same field

Cell Environment - Genopole's company

Cell Environment

Cell Environment is a company focusing on DNA damage detection involving unique and repeated sequences such as telomere and centromere sequences.

Discover
Innovhem - Entreprise génopolitaine

Innovhem

Our mission is to improve the management of Red Blood Cell diseases and in particular Sickle Cell Disease

Discover
Logo Integragen - Genopole's Company

Integragen

IntegraGen’s mission is to translate molecular research to clinical practice through the identification of novel genetic biomarkers and the subsequent commercialization of molecular diagnostic tests based on these discoveries.

Discover
logo GenoSplice - Genopole's Company

GenoSplice

Bioinformatics service provider (gene expression, splicing, SNP, CNV, epigenetics, data integration).

Discover
Enalees - Genopole's company

Enalees

Enalees conceives, develops and markets next-generation rapid molecular diagnosis tests for veterinarians, and furthermore screening tests for SARS-CoV-2.

Discover
AgenT Biotech - entreprise génopolitaine

AgenT

AgenT is developing an unprecedented blood test to identify patients with Alzheimer's disease much earlier in disease course than current detection methods are able to do. The company also does drug repositioning research to identify compounds potentially active in the silent phase of Alzheimer's disease.

Discover
View all >
With the support from